Early Corticosteroid Exposure after BCMA CAR-T in Multiple Myeloma: Dose-Dependent Impact on Outcomes and Toxicities.

Key Points

• Corticosteroid exposure significantly influences patient outcomes and toxicities associated with BCMA CAR-T therapy.
• Higher doses of corticosteroids correlate with increased toxicities, impacting overall treatment effectiveness.
• Analysis across multiple centers highlights the need for careful dose management of corticosteroids post-therapy.
• Findings suggest that optimizing corticosteroid use could enhance patient safety in multiple myeloma treatment.